WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Inc Stock Ownership - Who owns Maze Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maze Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard H. SchellerDirector2025-09-1520,744$22.37
$464.04kSell

1 of 1

MAZE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MAZE insiders and whales buy or sell their stock.

MAZE Shareholders

What type of owners hold Maze Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures IV LP16.02%7,024,758$163.33MInsider
Trv GP IV LLC13.85%6,073,958$141.22MInstitution
Frazier Life Sciences Management LP10.42%4,567,275$106.19MInstitution
Arch Venture Management LLC9.40%4,120,053$95.79MInstitution
Deep Track Capital LP9.01%3,948,910$91.81MInstitution
Matrix Capital Management Company LP5.67%2,486,184$57.80MInstitution
Alphabet Inc5.50%2,412,471$56.09MInstitution
Foresite Capital Management IV LLC4.82%2,111,919$49.10MInstitution
Ah Capital Management LLC3.88%1,702,225$39.58MInstitution
Janus Henderson Group PLC3.20%1,401,260$32.58MInstitution

1 of 3

MAZE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MAZE82.99%17.01%Net SellingNet Selling
SION63.96%36.04%Net BuyingNet Selling
MDXG46.34%53.66%Net BuyingNet Buying
ORIC81.27%18.73%Net SellingNet Selling
ATAI13.61%38.27%Net BuyingNet Buying
View Top Biotech Stocks

Maze Therapeutics Stock Ownership FAQ

Who owns Maze Therapeutics?

Maze Therapeutics (NASDAQ: MAZE) is owned by 88.56% institutional shareholders, 18.15% Maze Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures IV LP is the largest individual Maze Therapeutics shareholder, owning 7.02M shares representing 16.02% of the company. Third Rock Ventures IV LP's Maze Therapeutics shares are currently valued at $164.80M.

If you're new to stock investing, here's how to buy Maze Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.